Drug Hunter
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > Merck IDO1 inhibitor
<< Back to March
heme-displacing IDO1 inhibitor
human predicted QD dose of 26 mg
from 260k MS-based screen and SBDD
ACS Med. Chem. Lett. Mar. 10, 2020
Merck, Boston, MA
Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)
Unlock this content with a Premium membership to read it now.
